2Gaede P,Lund AndersenH,Parving HH,et al.Effect of a muhifactorial intervention on mortality in type 2 diabetes.N Engl J Med,2008,358:580-591.
3Ramachandran A,Wan Ma RC.Snehalatha C.Diabetes in Asis.The Lancet,2009,375:408-418.
4Rolim LC,Sá JR,Chacra AR,et al.Clinical heterogeneity and coexistence of diabetic neuropathies:difference and similarities between types 1 and 2 diabetes mellitus.Arq Bras Endocrinol Metabol,2009,53:818-824.
5Sugimoto K,Yasujima M,Yagihashi S.Role of advanced glyeation end products in diabetie neuropathy.Curr Pharm Des,2008,14:953-961.
6Vincent AM,Hayes JM,McLean LL,et al.Dyslipidemia-induced neuropathy in mice:the role of oxLDL/LOx-1.Diabetes,2009,58:2376-2385.
7Wiggin TD,Sullivan KA,Pop-Busui R,et al.Elevated triglycerides correlate with progression of diabetic neuropathy.Diabetes,2009,58:1634-1640.
8Davis TM,Yeap BB,Davis WA,et al.Lipid-lowering therapy and peripheral sensory neuropathy in type 2 diabetes:the Fremantle Diabetes Study.Diabetolosia,2008,51:562-566.
9Fernyhough P,Calcutt NA.Abnormal calcium homeostasis in peripheral neuropathies.Cell Calcium,2009 Dec 22.doi:10.1016.
10Obrosava IG,Li F,Abatan OI,et al.Role of poly(ADP-ribose)polymerase activation in diabetic neuropathy.Diabetes,2004,53:711-720.
